课题基金 / 基金详情

STUDY OF HU1124 IN MODERATE TO SEVERE PLAQUE PSORIASIS

STUDY OF HU1124 IN MODERATE TO SEVERE PLAQUE PSORIASIS
HU1124 在中度至重度斑块状银屑病中的研究
批准号:
6274759
负责人:
Sewon Kang
金额:
$2.15万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

Sewon Kang的其他基金

相似基金

相关文献

中文摘要
翻译
这是第一阶段,开放标签,单剂量,剂量递增,多中心
英文摘要
This is a phase-I, open-label, single-dose, dose-escalation, multicenter study of the effect of hu1124 on approximately 4-6 patients with moderate to severe plaque psoriasis. Patients will receive one intravenous infusion and will be assessed by clinical and laboratory examination for evidence of toxicity and biologic response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
P3: Infrared Irradiation and Scleroderma Skin
OPEN LABEL STUDY OF TETRATHIOMOLYBDATE IN TREATMENT OF PSORIASIS VULGARIS
Univ of Michigan Multidisciplinary Clinical Resea**(RMI)
University of Michigan Multidisciplinary Clinical Research (RMI)
海外基金